Sanger Clinic About Sanger: Active Studies
Active Studies

Sanger Clinic has a long history of pioneering new procedures and techniques that benefit our patients. Below is a list of the current research studies we are involved in:

ACROSS
· Chronic Total Occlusion Registry.

Category: Interventional
Status: Start-Up
Investigator: Charles A. Simonton, III, M.D.
ACTIVATE
· A randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of the ACAT Inhibitor CS-505 for reducing the progression of atherosclerosis in subjects with coronary artery disease using Intravasclar Ultrasound (IVUS).

Category: Pharmacology
Status: Follow-Up
Investigator: Glen J. Kowalchuk, M.D.
AneuRx III
· A Phase III Evaluation of the safety and efficacy of the AneuRx Stent Graft System in the treatment of Abdominal Aortic Aneurysms (AAA).

Category: Vascular
Status: Long-Term Follow-Up
Investigator: Timothy S. Roush, M.D.
Cabernet
· Carotid Artery Revascularization using the Boston Scientific EPI FilterWire EX (TM) and EndoTex (TM) NexStent (TM).

Category: Vascular
Status: Follow-Up
Investigator: Michael J. Rinaldi, M.D.
Cafe
· Cardioablate Atrial Fibrillation Elimination.

Category: CV Surgery
Status: Start-Up
Investigator: R. Mark Stiegel, M.D.
CAPTURE
· Carotid Rx Acculink/Accunet Post Approval Trial to uncover unanticipated or rare events-CAPTURE.

Category: Vascular
Status: Enrolling
Investigator: Michael J. Rinaldi, M.D.
CASES-PMS
· Carotid Artery Stenting with Embolic Protection Surveillance-Post Marketing Study.

Category: Vascular
Status: Start-Up
Investigator: Michael J. Rinaldi, M.D.
CREST
· Carotid Revascularization Endarteretomy-Stenting Trial (CREST).

Category: NIH Vascular
Status: Study Enrolling
Investigator: Michael J. Rinaldi, M.D.
ENDEAVOR IV
· Medtronic Drug Eluting Stent.

Category: Interventional
Status: Hold
Investigator: B. Hadley Wilson, M.D.
EVEREST I
· A study of the Evalve Cardiovascular Valve Repair System (CVRS) Endovascular Valve Edge-to-Edge Repair Study.

Category: Vascular
Status: Start-Up
Investigator: Michael J. Rinaldi, M.D.
EVEREST II
· A study of Evalve Cardiovascular Valve Repair System versus Mitral Valve Surgical Repair.

Category: Vascular
Status: Start-Up
Investigator: Michael J. Rinaldi, M.D.
Gamma V
· A multicenter trial of localized radiation therapy to inhibit restenosis.

Category: Interventional
Status: Follow-Up
Investigator: Charles A. Simonton, III, M.D.
In Sync Registry
· Biventricular pacing in patients with low ejection fraction.

Category: Electrophysiology
Status: Enrolling
Investigator: Paul G. Colavita, M.D.
Jo Stent SVG
· The Barrier Approach to Restenosis: Restrict Intima and curtail adverse events.

Category: Interventional
Status: Follow-Up
Investigator: Charles A. Simonton, III, M.D.
Madit crt
· Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy.

Category: Electrophysiology
Status: Start-Up
Investigator: Paul G. Colavita, M.D.
PROXIMAL
· Proximal protection during saphenous vein graft intervention using the PROXIS Embolic Protection System: A randomized, prospective, multicenter, clinical trial.

Category: Interventional
Status: Enrolling
Investigator: Charles A. Simonton, III, M.D.
QUANTUM LPS-Endovascular
· A prospective, multicenter study of the Quantum LP Stent Graft System for the treatment of abdominal aortic aneurysms - endovascular group.

Category: Vascular
Status: Enrolling
Investigator: Timothy S. Roush, M.D.
RABBIT
· Rapid Assessment of Bedside BNP in Treatment of heart failure.

Category: Congestive Heart Failure
Status: Study Enrolling
Investigator: Sanjeev K. Gulati, M.D.
SIRIUS
· A multicenter, randomized, double blind study of the Sirolimus-Coated BX Velocity TM Balloon-Expandable Stent in the treatment of patients with De Novo Coronary Artery Lesions.

Category: Interventional
Status: Follow-Up
Investigator: Charles A. Simonton, III, M.D.
TALENT LPS Enhanced
· An investigation of the TALENT LPS a low profile Endoluminal Spring Stent-Graft System for the treatment of sub-renal abdominal aortic aneurysms in patients who are candidates of standard surgical intervention.

Category: Vascular
Status: Follow-Up
Investigator:
TAXUS IV
· A prospective, randomized trial evaluating the TAXUS Paclitaxel Eluting Coronary Stent in De Novo Coronary Lesions and In-Stent Restenosis.

Category: Interventional
Status: Follow-Up
Investigator: B. Hadley Wilson, M.D.
Timi-38
· A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome subjects who are to undergo Percutaneous Coronary Intervention/TIMI-38.

Category: Pharmaceutical
Status: Start-Up
Investigator: Glen J. Kowalchuk, M.D.
Trivascular
· Aortic Stent Graft.

Category: Vascular
Status: Start-Up
Investigator: Jeremiah H. Holleman, Jr., M.D.
VALOR
· Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the treatment of thoracic aortic aneurysm/lesions.

Category: Vascular
Status: Enrolling
Investigator: Timothy S. Roush, M.D.
WALLGRAFT
· WALLGRAFT Endoprosthesis and the Unistep LS Delivery System for peripheral aneurysm and trauma.

Category: Vascular
Status: Follow-Up
Investigator: Timothy S. Roush, M.D.
top
Emma Neil Ogle, RN, RDCS
Senior Echo Technologist
After more than 20 years at Sanger, I can honestly say I still truly like my job! It is so nice to work with physicians of all backgrounds from all over the country that want to share their knowledge, ideas and techniques with me. It is so nice to work with these "docs" that care for their patients as well as their staff. I feel appreciated and there is mutual respect between the clinical staff and the physicians. I am always learning something new and being challenged. Even on the busiest and most hectic days, someone inevitably causes me to smile! Sanger has always kept up with the newest and most advanced technology and is at the forefront of this advancing field, changing for the best. That is the most exciting element for me. Everything we learn from this new technology enhances patient care. There is a very personal touch to this office and hospital. Sanger makes it a point to provide close follow up with their patients and after 20 years here, it is nice to see these "ol friends"-hugs are always the norm.